419 related articles for article (PubMed ID: 11204935)
1. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
[TBL] [Abstract][Full Text] [Related]
2. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
[TBL] [Abstract][Full Text] [Related]
3. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
[TBL] [Abstract][Full Text] [Related]
5. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR; Balfour JA
Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
[TBL] [Abstract][Full Text] [Related]
6. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
Wang D; Miller R; Zheng J; Hu C
J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
[TBL] [Abstract][Full Text] [Related]
8. PHARMACOKINETICS OF PIROXICAM IN CRANES (FAMILY GRUIDAE).
Keiper NL; Cox SK; Doss GA; Elsmo B; Franzen-Klein D; Hartup BK
J Zoo Wildl Med; 2017 Sep; 48(3):886-890. PubMed ID: 28920805
[TBL] [Abstract][Full Text] [Related]
9. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
Dolci G; Ripari M; Pacifici L; Umile A
Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
[TBL] [Abstract][Full Text] [Related]
11. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
Lister RE; Acerbi D; Cadel S
Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
[TBL] [Abstract][Full Text] [Related]
12. Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.
Lapicque F; Vergne P; Jouzeau JY; Loeuille D; Gillet P; Vignon E; Thomas P; Velicitat P; Türck D; Guillaume C; Gaucher A; Bertin P; Netter P
Clin Pharmacokinet; 2000 Nov; 39(5):369-82. PubMed ID: 11108435
[TBL] [Abstract][Full Text] [Related]
13. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
[TBL] [Abstract][Full Text] [Related]
14. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
Cadel S; Bongrani S
Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
[No Abstract] [Full Text] [Related]
15. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT; Brunetto AV; Mattila MJ
Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
[TBL] [Abstract][Full Text] [Related]
17. Total and free plasma and total synovial fluid piroxicam concentrations: relationship to antiinflammatory effect in patients with reactive arthritis and other arthritides.
Hundal O; Kvien TK; Glennås A; Andrup O; Karstensen B; Thoen JE; Rugstad HE
Scand J Rheumatol; 1993; 22(4):183-7. PubMed ID: 8356411
[TBL] [Abstract][Full Text] [Related]
18. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
[TBL] [Abstract][Full Text] [Related]
19. Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
Karim A; Noveck R; McMahon FG; Smith M; Crosby S; Adams M; Wilton J
J Clin Pharmacol; 1997 Apr; 37(4):267-78. PubMed ID: 9115051
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
Dolci G; Ripari M; Pacifici L; Umile A
Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
